Suppr超能文献

新的和慢性皮质病变对多发性硬化症残疾累积的影响。

Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis.

作者信息

Beck Erin S, Mullins W Andrew, Dos Santos Silva Jonadab, Filippini Stefano, Parvathaneni Prasanna, Maranzano Josefina, Morrison Mark, Suto Daniel J, Donnay Corinne, Dieckhaus Henry, Luciano Nicholas J, Sharma Kanika, Gaitán María Ines, Liu Jiaen, de Zwart Jacco A, van Gelderen Peter, Cortese Irene, Narayanan Sridar, Duyn Jeff H, Nair Govind, Sati Pascal, Reich Daniel S

机构信息

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Brain Commun. 2024 May 2;6(3):fcae158. doi: 10.1093/braincomms/fcae158. eCollection 2024.

Abstract

Cortical lesions are common in multiple sclerosis and are associated with disability and progressive disease. We asked whether cortical lesions continue to form in people with stable white matter lesions and whether the association of cortical lesions with worsening disability relates to pre-existing or new cortical lesions. Fifty adults with multiple sclerosis and no new white matter lesions in the year prior to enrolment (33 relapsing-remitting and 17 progressive) and a comparison group of nine adults who had formed at least one new white matter lesion in the year prior to enrolment (active relapsing-remitting) were evaluated annually with 7 tesla (T) brain MRI and 3T brain and spine MRI for 2 years, with clinical assessments for 3 years. Cortical lesions and paramagnetic rim lesions were identified on 7T images. Seven total cortical lesions formed in 3/30 individuals in the stable relapsing-remitting group (median 0, range 0-5), four total cortical lesions formed in 4/17 individuals in the progressive group (median 0, range 0-1), and 16 cortical lesions formed in 5/9 individuals in the active relapsing-remitting group (median 1, range 0-10, stable relapsing-remitting versus progressive versus active relapsing-remitting = 0.006). New cortical lesions were not associated with greater change in any individual disability measure or in a composite measure of disability worsening (worsening Expanded Disability Status Scale or 9-hole peg test or 25-foot timed walk). Individuals with at least three paramagnetic rim lesions had a greater increase in cortical lesion volume over time (median 16 µl, range -61 to 215 versus median 1 µl, range -24 to 184, = 0.007), but change in lesion volume was not associated with disability change. Baseline cortical lesion volume was higher in people with worsening disability (median 1010 µl, range 13-9888 versus median 267 µl, range 0-3539, = 0.001, adjusted for age and sex) and in individuals with relapsing-remitting multiple sclerosis who subsequently transitioned to secondary progressive multiple sclerosis (median 2183 µl, range 270-9888 versus median 321 µl, range 0-6392 in those who remained relapsing-remitting, = 0.01, adjusted for age and sex). Baseline white matter lesion volume was not associated with worsening disability or transition from relapsing-remitting to secondary progressive multiple sclerosis. Cortical lesion formation is rare in people with stable white matter lesions, even in those with worsening disability. Cortical but not white matter lesion burden predicts disability worsening, suggesting that disability progression is related to long-term effects of cortical lesions that form early in the disease, rather than to ongoing cortical lesion formation.

摘要

皮质病变在多发性硬化症中很常见,与残疾和疾病进展相关。我们询问在白质病变稳定的人群中皮质病变是否继续形成,以及皮质病变与残疾恶化之间的关联是与既往存在的还是新出现的皮质病变有关。对50名在入组前一年无新白质病变的成年多发性硬化症患者(33例复发缓解型和17例进展型)以及9名在入组前一年至少形成一个新白质病变的成年对照组(活动复发缓解型)进行了为期2年的每年一次的7特斯拉(T)脑部磁共振成像(MRI)以及3T脑部和脊柱MRI检查,并进行了3年的临床评估。在7T图像上识别出皮质病变和顺磁性边缘病变。在稳定复发缓解组的30人中,有3人共形成了7个皮质病变(中位数为0,范围为0 - 5);在进展组的17人中,有4人共形成了4个皮质病变(中位数为0,范围为0 - 1);在活动复发缓解组的9人中,有5人共形成了16个皮质病变(中位数为1,范围为0 - 10,稳定复发缓解型与进展型与活动复发缓解型相比,P = 0.006)。新的皮质病变与任何个体残疾指标或残疾恶化的综合指标(扩展残疾状态量表恶化或9孔插针试验或25英尺定时步行)的更大变化均无关联。至少有三个顺磁性边缘病变的个体,其皮质病变体积随时间增加更大(中位数为16微升(µl),范围为 - 61至215,而中位数为1微升,范围为 - 24至184,P = 0.007),但病变体积变化与残疾变化无关。残疾恶化人群的基线皮质病变体积更高(中位数为(1010)微升,范围为13 - 9888,而中位数为(267)微升,范围为0 - 3539,P = 0.001,经年龄和性别校正),以及复发缓解型多发性硬化症患者中随后转变为继发进展型多发性硬化症的个体(中位数为(2183)微升,范围为270 - 9888,而仍为复发缓解型的患者中位数为(321)微升,范围为0 - 6392,P = 0.01,经年龄和性别校正)。基线白质病变体积与残疾恶化或从复发缓解型转变为继发进展型多发性硬化症无关。在白质病变稳定的人群中,即使是那些残疾恶化的人群,皮质病变形成也很罕见。皮质而非白质病变负担可预测残疾恶化,这表明残疾进展与疾病早期形成的皮质病变的长期影响有关,而非与持续的皮质病变形成有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d384/11137753/78e9ab84b88e/fcae158_ga.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验